Recalls / Active ingredient / Daptomycin
Daptomycin
3 FDA drug recalls involving the active ingredient “Daptomycin” — 1 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2023-02-07 | Class II | Daptomycin for Injection 500 mg per vial, Single-dose vial, Rx only, Manufactured by: Intas Pharmaceuticals Li | Accord Healthcare, Inc. |
| 2023-02-07 | Class II | Daptomycin for Injection 350 mg/vial, Rx only, Packaged as: a) Single-dose vial NDC 16729-434-05 UPC 3 16729 4 | Accord Healthcare, Inc. |
| 2020-07-07 | Class I | Daptomycin for Injection, 500 mg/vial, Single-Dose Vial, Rx only, Sterile, Manufactured for: Mylan Institution | Mylan Institutional LLC |